Prognostic factors in pulmonary hypertension

Area of Science:

• Cardiology
• Pulmonary Medicine
• Clinical Research

Background:

• Pulmonary hypertension (PH) is defined by elevated mean pulmonary pressure (≥25 mm Hg).
• Assessing PH severity and prognosis is vital for patient management and therapeutic decisions.
• Understanding prognostic factors aids in predicting patient outcomes.

Purpose of the Study:

• To identify adverse prognostic factors in patients with pulmonary hypertension (PH).
• To evaluate the impact of these factors on mortality, quality of life, and hospitalization.
• To inform clinical decision-making and improve patient care.

Main Methods:

• A prospective study of 553 PH patients was conducted.
• Data collected included demographic, clinical, echocardiographic, and hemodynamic parameters.
• Correlations were analyzed between parameters and outcomes like mortality and hospitalization.

Main Results:

• Key adverse prognostic factors identified include WHO functional class III/IV, elevated pulmonary artery systolic pressure, right chamber dilation, and pericardial effusion.
• Other significant factors include reduced TAPSE, low cardiac index, and elevated right atrial pressure.
• These factors were correlated with increased mortality and hospitalization.

Conclusions:

• Pulmonary hypertension remains a serious disease with variable prognosis.
• Prognosis is influenced by etiology, functional class, and clinical, echocardiographic, and hemodynamic parameters.
• Identifying negative prognostic factors is essential for optimizing PH patient management.